Home Categories Send inquiry

Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4 Purity >99.5% E.E >99.5%

Ruifu Chemical Supply Intermediates of Saxagliptin Saxagliptin CAS 361442-04-8 Saxagliptin Hydrate CAS 945667-22-1 (R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4 Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4 Saxagliptin-N-Boc Amide CAS 361440-67-7 (R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
Chemical Name Boc-3-Hydroxy-1-Adamantyl-D-Glycine
Synonyms (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-Hydroxyadamantan-1-yl)acetic Acid; Saxagliptin Impurity 23; Saxaint-G; Saxaint-I; Saxagliptin II; Saxagliptin INT 3; Saxagliptin Intermediate 3; Vildagliptin Intermediate D
CAS Number 361442-00-4
CAT Number RF-PI1989
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C17H27NO5
Molecular Weight 325.40
Boiling Point 497.3±20.0℃
Density 1.296
Brand Ruifu Chemical
Item Specifications
Appearance White or Off-White Crystalline Powder
Water (K.F) <0.50%
Loss on Drying <1.00%
Residue on Ignition <0.50%
Single Impurity <0.50%
Total Impurities <0.50%
E.E >99.5%
Purity >99.5%
Infrared Spectrum Conforms to Structure
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture Boc-3-Hydroxy-1-Adamantyl-D-Glycine (CAS: 361442-00-4) is an intermediate of Saxagliptin (CAS: 361442-04-8). Saxagliptin is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration an d has a pharmacokinetic profile compatible with once daily dosing. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor antidiabetic for the treatment of type 2 diabetes. DPP-4 inhibitors are a class of compounds that work by affecting the action of natural hormones in the body called incretins. Saxagliptin is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Saxagliptin is not for treating type 1 diabetes. Saxagliptin is sometimes used in combination with other diabetes medications. It was reached by the cooperation of AstraZeneca and Bristol-Myers Squibb Company and belongs to DPP-IV inhibitor.